Incidence and clinical characteristics of second malignant neoplasms in children: A multicenter study of a polish pediatric leukemia/lymphoma group

Medical Science Monitor

Volumn 10, Issue 3, 2004, Pages

  Kowalczyk, Jerzy R ^a,c   Nurzyńska, Joanna ^a   Armata, Jerzy ^b   Bogusławska Jaworska, Janina ^a   Rokicka Milewska, Roma ^a   Sońta Jakimczyk, Danuta ^a   Balwierz, Walentyna ^b   Chybicka, Alicja ^a   Kaczmarek Kanold, Małgorzata ^a   Wachowiak, Jacek ^a   Matysiak, Michał ^a   Pawelec, Katarzyna ^a  

^a Dept of Pediat Hematology/Oncology ^*  (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

^c University Children's Hospital   (Poland)

Author keywords

Children; Leukemia; Lymphoma; Second malignant neoplasms

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; MITOMYCIN C; VINDESINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CLINICAL FEATURE; FOLLOW UP; HODGKIN DISEASE; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; POLAND; SECOND CANCER; SOFT TISSUE SARCOMA; THYROID CARCINOMA;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; INCIDENCE; INFANT; LEUKEMIA; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; NEOPLASMS, SECOND PRIMARY; SARCOMA; SOFT TISSUE NEOPLASMS; THYROID NEOPLASMS; TIME FACTORS;

EID: 12144286103     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Lavey RS, Eby NL, Prosnitz LR: Impact on second malignancy risk of the combined use of radiation and chemotherapy for lymphomas. Cancer, 1990; 66: 80-88
2. Petru E, Schmahl D: Cytotoxic chemotherapy-induced second primary neoplasm: clinical aspects. Neoplasma, 1991; 38: 147-55
3. Pui C-H, Behm FG, Raimondi SC et al: Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. N Eng J Med, 1989; 321: 136-42
4. Tester WJ, Kinsella TJ, Waller B et al: Second malignant neoplasms complicating Hodgkin's disease: The National Cancer Institute experience. Clin Oncol, 1984; 2: 762-69
5. Whitlock JA, Greer JP, Lukens JN: Epipodophyllotoxin-related leukemia. Cancer, 1991; 68: 600-4
6. Olsen JH: Risk of second cancer after cancer in childhood. Cancer, 1986; 57: 2250-54
7. Kowalczyk JR, Dudkiewicz E, Balwierz W et al: Incidence of childhood cancers in Poland in, 1995-1999. Med Sci Monit, 2002; 8: 587-90
8. Pedersen-Bjergaard J, Preben P, Pedersen NT et al: Acute nonlymphocytic leukemia preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. Cancer, 1984; 54: 452-62
9. Meadows A, Baum E, Fossati-Bellani F et al: Second malignant neoplasms in children: an update from the late effects study group. J Clin Oncol. 1985; 3: 532-38
10. Mike V, Meadows AT, D'Angio GJ: Incidence of second malignant neoplasms in children: Results of an international study. Lancet, 1982; 2: 1326-31
11. Ingram L, Mott M, Mann J et al: Second malignancies in children treated for non-Hodgkin's lymphoma and T-cell leukemia with the UKCCSC regimens. Br J Canc, 1987; 55: 463
12. Neglia JP, Meadows AT, Robinson LL et al: Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med, 1991; 325: 1330-36
13. Nygaard R, Garwicz S, Haldorsen T et al: Second malignant Neoplasms in patients treated for childhood leukemia. Acta Paediatr Scand, 1991; 80: 1220-28
14. Rosso P, Terracini B, Fears TR et al: Second malignant tumors after efective end of therapy for a first cancer in childhood: A multicenter study in Italy. Int J Cancer, 1994; 59: 451-56
15. Bhatia S, Sather HN, Pabustan OB et al: Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after, 1983. Blood, 2002; 99(12): 4257-64
16. Loning L, Zimmermann M, Reiter A et al: Secondary neoplasms subsequent to Berlin-Frankfurt-Munster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy. Blood, 2000; 95(9): 2770-75
17. Bhatia S, Rohinson LL, Oberlin O et al: Breast cancer and other second neoplasms after childhood Hodgkin's disease. T N Engl J Med, 1996; 334: 745-51
18. Beaty O III, Hudson MM, Greenwald C et al: Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease. J Clin Oncol, 1995; 13: 603-9
19. Sankila R, Garwicz S, Olsen JH et al: Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: A population-based cohort study in the five nordic countries. J Clin Oncol, 1996; 14: 1442-46
20. Van Leeuwen FE, Klokman WJ, Hagenbeek A et al: Second cancer risk following Hodgkin's disease: A 20-year follow-up study. J Clin Oncol, 1994; 12: 312-25
21. Schellong G, Riepenhausen M, Creutzig U et al: Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. J Clin Oncol, 1997; 15: 2247-53
22. Bramswing JH, Korinthenberg R, Gutjahr P: Late effects of antineoplastic chemo- and radiotherapy on the gonad's, the nervous system and the occurrence of second malignancies. Monogr Paediat, 1986; 18: 84-97
23. Andrieu JM, Ifralt N, Payen C et al: Increased risk of secondary acute nonlymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin's disease. J Clin Oncol 1990; 8: 1148-54
24. Green DM, Hyland A, Barcos MP et al: Second malignant neoplasms after treatment for Hodgkin's disease in childhood or adolescence. Clin Oncol, 2000, 18(7): 1492-99
25. Benitez J, Carbonell F, Ferro T et al: Cytogenetic studies in 18 patients with secondary blood disorders. Cancer Genet Cytogenet, 1986; 22: 309-17
26. Kapadia SB, Krause JR, Ellis LD et al: Induced acute non-lymphocytic leukemia following long-term chemotherapy. Cancer, 1982; 45: 1315-21
27. Fourth International Workshop on Chromosomes in Leukemia, 1982: Secondary leukemias associated with neoplasia: treated and untreated. Cancer Genet Cytogenet, 1984; 11: 319-21
28. Sozzi G, Miozzo M, Orazi A et al: Cytogenetic study in therapy-related myelodysplastic syndromes (t-MDS) and acute non-lymphocytic leukemia (t-ANLL). Br J Cancer, 1990; 61: 425-28
29. Grunwald HW, Rosner F: Acute myeloid leukemia following treatment of Hodgkin's disease. Cancer, 1982; 50: 676-83
30. Fenaux P, Lai JL, Qiuquandon I et al: Therapy related myelodys-plastic syndrome and leukemia with no "unfavourable" cytogenetic findings have a good response to intensive chemotherapy: a report on 15 cases. Leuk Lymph, 1991; 5: 117-25
31. Kantarjian HM, Keating MJ, Walters RS et al: The association of specific "favorable" cytogenetic abnormalities with secondary leukemia. Cancer, 1986; 58: 924-27
32. Kowalczyk JR: Cytogenetics of secondary leukemias. In: Becher R, Sandberg AA, Schmidt GG (eds.) Chromosomes in Hematology. W. Zuckschwerdt Verlag, Munchen, 1986
33. Sandberg AA, Abe S, Kowalczyk JR et al: Chromosomes and causation of human cancer and leukemia. Cancer Genet Cytogenet, 1982; 7: 95-136
34. Travis LB, Curtis RE, Boice JD et al: Second cancers following non-Hodgkin's lymphoma. Cancer, 1991; 67: 2002-9